文章摘要

文章信息/Info

Title:: -

作者:: 傅羽¹; 尹新华¹; 张一娜²; 哈尔滨医科大学附属第二医院：1.心内科，2.老年病科，黑龙江哈尔滨 150086

Author(s):: -

关键词:: 组织因子途径抑制物; 血管成形术; 再狭窄; 基因治疗

Keywords:: -

分类号:: R543

DOI:: -

文献标识码:: A

摘要:: 组织因子途径抑制物是凝血过程的启动子(组织因子)的特异性生理抑制物，属Kunitz型蛋白酶抑制剂。许多国内外的研究表明它能够预防血栓形成、溶栓后血管再闭塞及血管成形术后再狭窄。其防治再狭窄的机制目前尚未完全阐明，可能与抑制血栓形成、血管重构、内膜增殖以及炎性反应等密切相关。本文将综述目前有关组织因子途径抑制物在血管成形术后再狭窄中的一些研究进展。

Abstract:: -

参考文献/References

［1］田建伟，赵连友，郑强荪. PTCA术后再狭窄机制的研究现状［J］.心脏杂志, 2002, 14(4): 353-355,358.

［2］ Kato Hisao. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor［J］.Arterioscler Thromb Vasc Biol，2002，22（4）：539-548.

［3］ Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications［J］. Circulation，2006，113(5)：722 - 731.

［4］ Ghrib F , Brisset AC , Dupouy D ,et al. The expression of tissue factor and tissue factor pathway inhibitor in aortic smooth muscle cells is upregulated in synthetic compared to contractile phenotype［J］. Thromb Haemost, 2002, 87(6): 1051-1056.

［5］ Rao L, Pendurthi U. Tissue factor factor VIIa signaling［J］.Arterioscler Thromb Vasc Biol, 2005, 25(1): 47 -56.

［6］ Lwaleed BA, Bass P. Tissue factor pathway inhibitor: structure, biology and involvement in disease［J］.Journal of Pathology, 2006, 208(3): 327 339.

［7］ Yin XH, Yutani C, Ikeda Y，et al. Tissue factor pathway inhibitor gene delivery using HVJAVE liposomes markedly reduces restenosis in atherosclerotic arteries［J］. Cardiovasc Res, 2002, 56（3）: 454-463.

［8］ Cirillo P，Calì G，Golino P，et al. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal–regulated kinase activation［J］. Circulation, 2004, 109(3): 2911-2916.

［9］顾俊，王长谦.基质金属蛋白酶与冠脉再狭窄［J］.心脏杂志, 2005, 17(1):77-80.

［10］Kopp CW, Hlzenbein T, Steiner S,et al. Inhibition of restenosis by tissue factor pathway inhibition: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity［J］. Blood, 2004, 103(5): 1653-1661.

［11］Baker AH，Edwards DR，Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities［J］. Journal of Cell Science, 2002, 115(19): 3719-3727 .

［12］Golino P. The inhibitors of the tissue factor:factor VII pathway［J］. Thrombosis Research, 2002, 106(3): V257-265.

［13］Nakamura Y, Nakamura K, Ohta K, et al. Antiinflammatory effects of longlasting locallydelivered human recombinant tissue factor pathway inhibitor after balloon angioplasty［J］. Basic Res Cardiol, 2002, 97(3): 198-205.

我们的网站为什么显示成这样？

组织因子途径抑制物与血管成形术后再狭窄(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics